Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

44.84 +1.31 (+3.01%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist

Price and Volume

Volume	562,543
Open	43.83
Bid (Size)	44.85 (100)
Ask (Size)	45.70 (400)
Prev. Close	43.53
Today's Range	43.62 - 44.94
52wk Range	23.23 - 44.94
Shares Outstanding	32,250,236
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Momentum Stocks with Exciting Potential and 1 We Find Risky

November 10, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook

November 07, 2025

Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 31.4% year on year to $209.4 million. The company’s full-year revenue...

Via StockStory

Performance

YTD	+56.6%	+56.6%
1 Month	+40.0%	+40.0%
3 Month	+18.4%	+18.4%
6 Month	+50.5%	+50.5%
1 Year	+39.3%	+39.3%

More News

Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today

November 06, 2025

Via StockStory

Earnings Scheduled For November 6, 2025

November 06, 2025

Via Benzinga

Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance

November 06, 2025

Via Chartmill

Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%

November 06, 2025

Via StockStory

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

November 06, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow

November 04, 2025

Via StockStory

3 Stocks Under $50 That Fall Short

October 31, 2025

Via StockStory

Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment

October 29, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

October 23, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Pharmaceutical (COLL): Buy, Sell, or Hold Post Q2 Earnings?

October 23, 2025

Via StockStory

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

October 22, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

October 13, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know

October 10, 2025

Via StockStory

1 Russell 2000 Stock to Research Further and 2 We Avoid

September 26, 2025

Via StockStory

Branded Pharmaceuticals Stocks Q2 Highlights: Collegium Pharmaceutical (NASDAQ:COLL)

September 24, 2025

Via StockStory

1 Safe-and-Steady Stock to Keep an Eye On and 2 Facing Headwinds

September 12, 2025

Via StockStory

Collegium to Participate in Upcoming Investor Conferences

August 28, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

August 25, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

1 Stock Under $50 Worth Investigating and 2 We Ignore

August 13, 2025

Via StockStory

3 Profitable Stocks We Think Twice About

August 12, 2025

Via StockStory

COLL Q2 Deep Dive: Jornay Expansion Drives Revenue Guidance Increase, Margins Face Investment Pressure

August 12, 2025

Via StockStory

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2%

August 07, 2025

Via StockStory

Collegium (COLL) Q2 Revenue Jumps 29%

August 07, 2025

Via The Motley Fool

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?

Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.

What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?

Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?

The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market

What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?

The current price of Collegium Pharmaceutical, Inc. - Common Stock is 44.84

When was Collegium Pharmaceutical, Inc. - Common Stock last traded?

The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 11/11/25 04:00 PM ET

What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?

The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.45B

How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?

Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.